EX-FILING FEES 3 tenx_ex107.htm FEE TABLE tenx_ex107.htm

  EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Tenax Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

 

Security Type

 

Security Class Title

 

Fee Calculation

Rule

 

Amount

Registered

 

Proposed

Maximum

Offering Price

Per Unit

 

Maximum

Aggregate

Offering

Price(1)

 

Fee Rate

 

Amount of

Registration

Fee

Fees to be Paid

Equity

Common stock, $0.0001 par value per share(2)

Rule 457(o)

—

—

$12,000,000(3)

$0.00014760

$1,771.20

 

Equity

Common Stock, $0.0001 par value per share, issuable upon the exercise of the Warrants(2)

 

Rule 457(o)

—

—

 

$24,000,000

 

$0.00014760

 

$3,542.40

 

Equity

Common Stock, $0.0001 par value per share, issuable upon the exercise of the Pre-Funded Warrants(2)

Rule 457(g)

—

—

—

—

(4)

 

Equity

Warrants

Rule 457(g)

—

—

—

—

(4)

 

Equity

Pre-Funded Warrants

Rule 457(g)

—

—

(3)

—

(4)

Fees Previously Paid

—

—

 

—

 

—

 

—

 

—

 

—

 

—

 

Total Offering Amounts

 

 

 

 

 

$36,000,000

 

 

 

$5,313.60

 

Total Fees Previously Paid

 

 

 

 

 

 

 

 

 

—

 

Total Fee Offsets

 

 

 

 

 

 

 

 

 

—

 

Net Fee Due

 

 

 

 

 

 

 

 

 

$5,313.60

 

(1)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended (the “Securities Act”).

(2)

Pursuant to Rule 416 under the Securities Act, this registration statement also registers an indeterminate number of shares of the registrant’s Common Stock which may become issuable by reason of any stock dividend, stock split or other similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s Common Stock.

(3)

The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $12,000,000.

(4)

No separate registration fee pursuant to Rule 457(g) of the Securities Act.